文章名稱(chēng)引用次數(shù)

• IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review28
• Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment28
• Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis20
• Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis17
• RANKL: A therapeutic target for bone destruction in rheumatoid arthritis16
• Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study14
• Safety, pharmacokinetics, and efficacy of E an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis13
• Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials13
• Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis12
• Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: The Yakumo study11